Literature DB >> 6286165

Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.

C J Oon, M A Friedman.   

Abstract

Primary hepatocellular cancer is a common and virulent malignancy found all over the world. New insights into this disease are being provided by evaluation of the impact of epidemiologic data (hepatitis viral exposure, race, sex, HLA typing, and environmental factors). An enhanced appreciation of the biochemical modulators of hepatocellular cancer metabolism is now also possible. The limited success of current therapies is far from satisfactory, but prospects for the future seem more varied and promising than ever before.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6286165     DOI： 10.1007/bf00255489

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


  30 in total

1.  Hypoglycemia in primary carcinoma of the liver.

Authors:  A J MCFADZEAN; T T YEUNG
Journal:  AMA Arch Intern Med       Date:  1956-12

2.  Influence of sex and sex hormones on development of hepatomas and other hepatic lesions in strain AX C rats ingesting 2-diacetylaminofluorene.

Authors:  H P MORRIS; H I FIRMINGER
Journal:  J Natl Cancer Inst       Date:  1956-02       Impact factor: 13.506

3.  Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial.

Authors:  G Falkson; C G Moertel; P Lavin; F J Pretorius; P P Carbone
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

Review 4.  Survival after liver resection for cancer.

Authors:  J H Foster
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

5.  Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study.

Authors:  M A Friedman; P A Volberding; M J Cassidy; K J Resser; T H Wasserman; T L Phillips
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

6.  Inhibition of the growth of Morris hepatoma No. 44 in rats after induction of hypothyroidism: evidence that Morris hepatomas are thyroid dependent.

Authors:  S Mishkin; H P Morris; M A Yalovsky; P V Murthy
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

7.  Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm.

Authors:  J S Macdonald; M E Lippman; P V Woolley; P P Petrucci; P S Schein
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

8.  Primary hepatocellular carcinoma in the Asian Pacific region.

Authors:  C J Oon; K Okuda; R Pang
Journal:  Ann Acad Med Singapore       Date:  1980-04       Impact factor: 2.473

9.  Screening and early treatment of primary liver cancer--with special reference to the east part of China.

Authors:  Z Y Tang
Journal:  Ann Acad Med Singap       Date:  1980-04       Impact factor: 2.473

10.  Hepatitis B surveillance in Singapore.

Authors:  K T Goh
Journal:  Ann Acad Med Singapore       Date:  1980-04       Impact factor: 2.473
View more
  4 in total

1.  Treatment of primary liver cancer in Singapore. A review of 3200 cases seen between January 1, 1977, and July 31, 1987.

Authors:  C J Oon; A Rauff; L K Tan
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Detection of hepatitis B virus surface antigen mutants in paraffin-embedded hepatocellular carcinoma tissues.

Authors:  W N Chen; C J Oon; M C Moh
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

3.  Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions.

Authors:  C J Oon
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 4.  A risk-benefit assessment of tamoxifen therapy.

Authors:  W H Catherino; V C Jordan
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.